Analysts Set Stericycle, Inc. (NASDAQ:SRCL) PT at $74.00

Shares of Stericycle, Inc. (NASDAQ:SRCL) have earned an average rating of “Hold” from the six analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $74.00.

Several equities analysts have commented on SRCL shares. Keefe, Bruyette & Woods increased their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Royal Bank of Canada restated a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. StockNews.com initiated coverage on Stericycle in a research report on Wednesday, September 25th. They set a “hold” rating on the stock. Finally, Truist Financial upped their target price on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th.

Stericycle Trading Up 0.1 %

Shares of NASDAQ:SRCL opened at $60.95 on Monday. The company has a market cap of $5.66 billion, a PE ratio of -277.05, a P/E/G ratio of 3.37 and a beta of 1.11. The company’s 50 day moving average is $59.63 and its two-hundred day moving average is $55.17. Stericycle has a 52 week low of $37.78 and a 52 week high of $61.77. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. The company had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. Equities analysts predict that Stericycle will post 2.29 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stericycle

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. grew its stake in Stericycle by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock worth $444,509,000 after buying an additional 52,576 shares during the period. Capital Research Global Investors lifted its position in shares of Stericycle by 11.4% during the first quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after purchasing an additional 679,974 shares in the last quarter. Earnest Partners LLC grew its holdings in Stericycle by 12.4% during the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock valued at $129,766,000 after purchasing an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Stericycle by 7.0% during the second quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock worth $126,238,000 after acquiring an additional 142,814 shares during the last quarter. Finally, Schroder Investment Management Group raised its position in shares of Stericycle by 8.1% in the 4th quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock valued at $86,217,000 after purchasing an additional 129,822 shares in the last quarter. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.